Key Drivers
- Margin strength
- Cash flow
- Liquidity squeeze
AIAI Summary
HLN is no longer a simple defensive compounder; with strong cash generation still intact but a weaker current ratio, active refinancing needs, and the Gas-X recall highlighting execution fragility, the stock looks like a wait-for-proof name until management demonstrates cleaner balance-sheet control and repeatable growth from India/digital initiatives.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Margin strength
- •Cash flow
- •Liquidity squeeze
HLN delivered strong profitability and free cash flow in FY2025, but weakening liquidity, heavy intangible assets, and a fairly rich valuation temper the overall investment case.
Price Behavior
Key Price Behavior Insights:
- •Support holding
- •Lower highs
- •Failed rebound
Over the last month, HLN has drifted lower but is still holding near $9.70-$9.80 support, while repeated failed rebounds and lower highs keep the near-term outlook cautious.
Rebound to $10.27-$10.28 failed, followed by lower highs and stalled recovery attempts
Sentiment & News
Key News Insights:
- •Sales quality
- •Hold outlook
- •Debt management
Haleon's latest results showed improving sales but weaker growth quality, leaving sentiment cautious with a Hold-rated outlook and a new debt tender offer.
The stock may stay range-bound near term as operational gains are offset by investor caution and ongoing balance-sheet actions
Similar Companies in Healthcare
Other companies in the same sector with AI ratings